Global Tubeless Insulin Pump Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Wearable Insulin Pumps, and Implantable Insulin Pumps.

By Technology;

Continuous Glucose Monitoring (CGM) Integrated Pumps, and Standard Tubeless Pumps.

By Component;

Pod/Patch, Remote, and Accessories.

By Distribution Channel;

Hospitals, Pharmacies, and E- Commerce.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn382161578 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Tubeless Insulin Pump Market (USD Million), 2021 - 2031

In the year 2024, the Global Tubeless Insulin Pump Market was valued at USD 1,367.81 million. The size of this market is expected to increase to USD 2,913.88 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 11.6%.

The global tubeless insulin pump market has witnessed significant growth in recent years, driven by the increasing prevalence of diabetes worldwide. Tubeless insulin pumps represent a transformative advancement in diabetes management, offering greater convenience and flexibility compared to traditional insulin delivery systems. These pumps are designed to be worn discreetly on the body, eliminating the need for external tubing, which has been a limitation in older models. With advancements in technology, these pumps have become more efficient, smaller, and user-friendly, allowing diabetic patients to manage their insulin delivery with greater ease.

One of the key factors fueling the growth of the tubeless insulin pump market is the rising global incidence of diabetes. According to the International Diabetes Federation, the number of people living with diabetes continues to grow, particularly in emerging economies where lifestyle changes and an aging population contribute to the rising prevalence. As diabetes becomes a global health challenge, the demand for innovative solutions like tubeless insulin pumps is increasing. These devices are especially popular among individuals who require continuous insulin delivery, as they offer precise control over blood glucose levels, improving quality of life and reducing complications associated with poor diabetes management.

The technological advancements in tubeless insulin pumps have made them more attractive to patients and healthcare providers alike. These pumps are equipped with smart features such as wireless connectivity, real-time data sharing, and integration with continuous glucose monitoring (CGM) systems. These capabilities not only enhance the accuracy of insulin delivery but also allow for better monitoring and adjustments. As a result, healthcare professionals can more easily tailor treatment plans to individual patient needs, improving overall diabetes management. Additionally, the growing preference for non-invasive and discreet treatment options has spurred the demand for tubeless insulin pumps, particularly among younger patients.

The market for tubeless insulin pumps is also being shaped by key factors such as product innovation, increasing healthcare expenditure, and the growing number of diabetes awareness campaigns. Leading market players are continuously working on the development of new and improved devices that offer better performance, extended battery life, and more comfortable wearability. With the increasing adoption of these devices across various regions, the global tubeless insulin pump market is expected to continue expanding, providing new opportunities for both manufacturers and patients alike. Furthermore, as healthcare systems evolve and diabetes management becomes a priority, the market is poised for further advancements that will enhance patient outcomes.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Technology
    3. Market Snapshot, By Component
    4. Market Snapshot, By Distribution Channel
    5. Market Snapshot, By Region
  4. Global Tubeless Insulin Pump Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising prevalence of diabetes
        2. Technological advancements in insulin delivery systems
        3. Increased patient preference for convenience and improved quality of life
      2. Restraints
        1. High cost of tubeless insulin pumps
        2. Limited reimbursement options
        3. Technical limitations and complexity of use
      3. Opportunities
        1. Expansion in emerging markets
        2. Increasing adoption of wireless and smart healthcare devices
        3. Growing focus on personalized diabetes care
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Tubeless Insulin Pump Market, By Product Type, 2021 - 2031 (USD Million)
      1. Wearable Insulin Pumps
      2. Implantable Insulin Pumps
    2. Global Tubeless Insulin Pump Market, By Technology, 2021 - 2031 (USD Million)
      1. Continuous Glucose Monitoring (CGM) Integrated Pumps
      2. Standard Tubeless Pumps
    3. Global Tubeless Insulin Pump Market, By Component, 2021 - 2031 (USD Million)
      1. Pod/Patch
      2. Remote
      3. Accessories
    4. Global Tubeless Insulin Pump Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Pharmacies
      3. E- Commerce
    5. Global Tubeless Insulin Pump Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Insulet Corporation.
      2. F. Hoffmann-La Roche Ltd
      3. Debiotech S.A
      4. CeQur
      5. Valeritas, Inc.
      6. Tandem Diabetes Care, Inc.
      7. Animas
      8. Medtrum Technologies
  7. Analyst Views
  8. Future Outlook of the Market